DNTH icon

Dianthus Therapeutics

50 hedge funds and large institutions have $23.4M invested in Dianthus Therapeutics in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

0% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 10

7% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 14

4% less funds holding

Funds holding: 5250 (-2)

Holders
50
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$12K
Puts
$9K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$4.81M
2
$3.62M
3
$3.01M
4
$2.64M
5
$1.75M
6
$1.56M
7
$1.14M
8
$596K
9
$486K
10
$463K
11
$411K
12
$370K
13
$313K
14
$284K
15
$264K
16
$199K
17
$189K
18
$154K
19
$144K
20
$125K
21
$122K
22
$121K
23
$121K
24
$111K
25
$77.4K